Weekly updateCompaniesRecruiting servicePost a job


    Company info:

  • 101-250
  • 2015
  • Durham, NC
  • 50-100M



Claim company profile

About company:

StrideBio is pioneering gene therapy technology to treat genetic diseases using adeno-associated viruses (AAVs). AAVs deliver DNA to target cells by packaging the DNA within a capsid. StrideBio is using their STRIVE Capsid platform, a differentiated discovery engine, to develop capsids with improved functionalities such as better safety profiles and easy manufacturing. The platform is driven by 3D capsid structures and improved functionalities are multiplexed onto single capsids. This enables StrideBio to expand their capsid arsenal and IP estate, both of which StrideBio will use for therapeutic translation. StrideBio’s lead candidate, ARVC, is due to start clinical trials soon and is, along with their remaining internal pipeline, focused on cardiovascular indications.


Claim company profile to post jobs directly on this page and this website.

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com